1
|
Munera-Campos M, Chicharro P, Gonzalez Quesada A, Florez Menendez A, de la Cueva Dovao P, Gimenez Arnau AM, Gilaberte Calzada Y, Rodríguez Serna M, Montero T, Silvestre Salvador JF, Elosua González M, Del Alcazar E, Santamaría C, Sánchez-Pérez J, Carretero Hernández G, Batalla Cebey A, Jin Suh Oh H, Mauleón Fernández C, Curto Barredo L, Bertolín M, Navarro Bielsa A, Ballano Ruiz A, Botella Estrada R, Arias Santiago S, Betlloch I, Roustan Gullón G, Rosell Díaz A, Descalzo MÁ, García-Doval I, Carrascosa JM. [[Translated article]]BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings. Actas Dermosifiliogr 2023:S0001-7310(23)00349-6. [PMID: 37172898 DOI: 10.1016/j.ad.2023.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 03/07/2023] [Indexed: 05/15/2023] Open
Abstract
BACKGROUND In recent years, remarkable improvements in our understanding of atopic dermatitis (AD) have revolutionized treatment perspectives, but access to reliable data from clinical practice is essential. MATERIALS AND METHOD The Spanish Atopic Dermatitis Registry, BIOBADATOP, is a prospective, multicenter database that collects information on patients of all ages with AD requiring systemic therapy with conventional or novel drugs. We analyzed the registry to describe patient characteristics, diagnoses, treatments, and adverse events (AEs). RESULTS We studied data entries for 258 patients who had received 347 systemic treatments for AD. Treatment was discontinued in 29.4% of cases, mostly due to a lack of effectiveness (in 10.7% of cases). A total of 132 AEs were described during follow-up. Eighty-six AEs (65%) were linked to a systemic treatment, most commonly dupilumab (39 AEs) and cyclosporine (38 AEs). The most common AEs were conjunctivitis (11 patients), headache (6), hypertrichosis (5), and nausea (4). There was 1 severe AE (acute mastoiditis) associated with cyclosporine. CONCLUSIONS Initial findings on AEs from the Spanish BIOBADATOP registry are limited by short follow-up times precluding comparisons or calculation of crude and adjusted incidence rates. At the time of our analysis, no severe AEs had been reported for novel systemic therapies. BIOBADATOP will help answer questions on the effectiveness and safety of conventional and novel systemic therapies in AD.
Collapse
Affiliation(s)
- M Munera-Campos
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain.
| | - P Chicharro
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - A Gonzalez Quesada
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Florez Menendez
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - P de la Cueva Dovao
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - A M Gimenez Arnau
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Y Gilaberte Calzada
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - M Rodríguez Serna
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - T Montero
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | | | - M Elosua González
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - E Del Alcazar
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| | - C Santamaría
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - J Sánchez-Pérez
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - G Carretero Hernández
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Batalla Cebey
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - H Jin Suh Oh
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - C Mauleón Fernández
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - L Curto Barredo
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - M Bertolín
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - A Navarro Bielsa
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - A Ballano Ruiz
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - R Botella Estrada
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - S Arias Santiago
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - I Betlloch
- Servicio de Dermatología. Hospital General Universitario Alicante, Alicante, Spain
| | - G Roustan Gullón
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - A Rosell Díaz
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - M Á Descalzo
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain
| | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain; Servicio de Dermatología. Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | - J M Carrascosa
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| |
Collapse
|
2
|
Munera-Campos M, Chicharro P, Gonzalez Quesada A, Florez Menendez A, de la Cueva Dovao P, Gimenez Arnau AM, Gilaberte Calzada Y, Rodríguez Serna M, Montero T, Silvestre Salvador JF, Elosua González M, Del Alcazar E, Santamaría C, Sánchez-Pérez J, Carretero Hernández G, Batalla Cebey A, Jin Suh Oh H, Mauleón Fernández C, Curto Barredo L, Bertolín M, Navarro Bielsa A, Ballano Ruiz A, Botella Estrada R, Arias Santiago S, Betlloch I, Roustan Gullón G, Rosell Díaz A, Descalzo MÁ, García-Doval I, Carrascosa JM. BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings. Actas Dermosifiliogr 2023:S0001-7310(23)00181-3. [PMID: 36935039 DOI: 10.1016/j.ad.2023.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 03/07/2023] [Indexed: 03/19/2023] Open
Abstract
BACKGROUND In recent years, remarkable improvements in our understanding of atopic dermatitis (AD) have revolutionized treatment perspectives, but access to reliable data from clinical practice is essential. MATERIALS AND METHOD The Spanish Atopic Dermatitis Registry, BIOBADATOP, is a prospective, multicenter database that collects information on patients of all ages with AD requiring systemic therapy with conventional or novel drugs. We analyzed the registry to describe patient characteristics, diagnoses, treatments, and adverse events (AEs). RESULTS We studied data entries for 258 patients who had received 347 systemic treatments for AD. Treatment was discontinued in 29.4% of cases, mostly due to a lack of effectiveness (in 10.7% of cases). A total of 132 AEs were described during follow-up. Eighty-six AEs (65%) were linked to a systemic treatment, most commonly dupilumab (39 AEs) and cyclosporine (38 AEs). The most common AEs were conjunctivitis (11 patients), headache (6), hypertrichosis (5), and nausea (4). There was 1 severe AE (acute mastoiditis) associated with cyclosporine. CONCLUSIONS Initial findings on AEs from the Spanish BIOBADATOP registry are limited by short follow-up times precluding comparisons or calculation of crude and adjusted incidence rates. At the time of our analysis, no severe AEs had been reported for novel systemic therapies. BIOBADATOP will help answer questions on the effectiveness and safety of conventional and novel systemic therapies in AD.
Collapse
Affiliation(s)
- M Munera-Campos
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain.
| | - P Chicharro
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - A Gonzalez Quesada
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Florez Menendez
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - P de la Cueva Dovao
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - A M Gimenez Arnau
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Y Gilaberte Calzada
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - M Rodríguez Serna
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - T Montero
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | | | - M Elosua González
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - E Del Alcazar
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| | - C Santamaría
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - J Sánchez-Pérez
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - G Carretero Hernández
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Batalla Cebey
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - H Jin Suh Oh
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - C Mauleón Fernández
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - L Curto Barredo
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - M Bertolín
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - A Navarro Bielsa
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - A Ballano Ruiz
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - R Botella Estrada
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - S Arias Santiago
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - I Betlloch
- Servicio de Dermatología. Hospital General Universitario Alicante, Alicante, Spain
| | - G Roustan Gullón
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - A Rosell Díaz
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - M Á Descalzo
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain
| | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain; Servicio de Dermatología. Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | - J M Carrascosa
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| |
Collapse
|